arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

RadNet, Inc.

RDNT
$72.26 ▲ +4.05 (+5.94%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
17 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Neutral
auto_awesome

Analytical Summary

RadNet, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $5.4B
Dividend Yield
Revenue Growth 11.5%
Op. Margin 3.0%
ROIC 1.5%
FCF / Share $3.97
Trailing P/E
Price / Book 4.9x
FCF Yield 5.5%
Debt / Equity 1.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.04B
↑ +11.5%
Net Income Profit after all expenses
$-18.65M
↓ -767.8%
Operating Margin Operating profit as % of sales
3.0%
↓ -46.9% 37th
FCF / Share Free cash flow per share
$3.97
↑ +24.6%
Long-Term Debt Long-term obligations
$1.09B
↑ +7.2%

Health Breakdown

Profitability
46
Returns
42
Financial Health
41
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters